BioMarin Pharmaceutical, Inc. (BMRN)
54.60
+1.36
(+2.55%)
USD |
NASDAQ |
May 06, 16:00
54.61
+0.01
(+0.02%)
After-Hours: 06:14
BioMarin Pharmaceutical SG&A Expense (TTM) : 946.91M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 383.49M |
| Ionis Pharmaceuticals, Inc. | 467.79M |
| Mirum Pharmaceuticals, Inc. | 257.03M |
| Hims & Hers Health, Inc. | 1.192B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |